Experienced in Factor 10 Deficiency

Benoit Guillet

Rennes, FR 
Clinical Trials:Currently Recruiting for 1 Trial
Experienced in Factor 10 Deficiency
Rennes, FR 
OverviewLocationsClinical Research

Overview

Benoit Guillet practices in Rennes, France. Mr. Guillet is rated as an Experienced expert by MediFind in the treatment of Factor 10 Deficiency. His top areas of expertise are Hemophilia A, Blood Clots, Acquired Hemophilia, and Hemophilia B.

His clinical research consists of co-authoring 40 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Factor 10 Deficiency.

Gender
Male

Locations

Rennes, France
Other Locations
Caen, France
Nantes, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Haemophilia and Bone Loss PHILEOS Study
Haemophilia and Bone Loss PHILEOS Study
Enrollment Status: Recruiting
Publish Date: April 01, 2025
Intervention Type: Biological, Radiation
Study Phase: Not Applicable
Outcome of Acquired Haemophilia With Steroid Combined With Cyclophosphamide Versus Steroid Combined With Rituximab (CREHA Study)
Outcome of Acquired Haemophilia With Steroid Combined With Cyclophosphamide Versus Steroid Combined With Rituximab (CREHA Study)
Enrollment Status: Completed
Publish Date: October 06, 2025
Intervention Type: Drug
Study Drugs: Steroid, Cyclophosphamide, Rituximab
Study Phase: Phase 3
Determinants and Consequences of the Transition to Adulthood Among Adolescents With Haemophilia - TRANSHEMO
Determinants and Consequences of the Transition to Adulthood Among Adolescents With Haemophilia - TRANSHEMO
Enrollment Status: Completed
Publish Date: February 14, 2023
Intervention Type: Other
Bleeding Risk Evaluation in Haemophilia Patients Under Antiplatelet Therapies
Bleeding Risk Evaluation in Haemophilia Patients Under Antiplatelet Therapies
Enrollment Status: Completed
Publish Date: January 23, 2020
Intervention Type: Other
View 3 Less Clinical Trials

40 Total Publications

F8 gene variants influence the response to desmopressin in hemophilia A carriers.
F8 gene variants influence the response to desmopressin in hemophilia A carriers.
Journal: Blood
Published: May 06, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Guillet's expertise for a condition
ConditionClose
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile